McKesson Corporation shares rose over 15% on Thursday after the company reported third-quarter fiscal 2026 results and an outlook that surpassed market expectations.
The Texas healthcare company revealed that revenues reached $106.2 billion in the quarter, an 11% increase year-over-year, driven by strong prescription volumes and significant growth in the oncology and multispecialty segments.
The management now anticipates total revenue growth between 12% and 16%. The company raised its adjusted earnings per share (EPS) outlook, expecting it to land in the range of $38.80 to $39.20 for fiscal 2026. McKesson stock traded 15.55% higher to sell for $949.8 at 12:10 pm ET.
https://breakingthenews.net/Article/Health-giant-McKesson-up-15-on-updated-outlook/65617455
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.